Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leukocyte Platelet-Rich Fibrin (L-PRF) is an autologous platelet concentrate derived from a patient's own blood. It's widely used in regenerative medicine, particularly in oral and maxillofacial surgeries, to enhance tissue healing and regeneration. ## What is L-PRF? L-PRF is a second-generation platelet concentrate developed by Choukroun et al. in response to legal restrictions on blood handling[2][3]. It consists of a dense fibrin network containing platelets, leukocytes, cytokines, and adhesive proteins including fibrinogen, fibronectin, vitronectin, and thrombospondin-1[2]. This creates a 3-dimensional cross-linked fibrin matrix that serves as a binding site for both platelets and growth factors[2]. ## Preparation Process The preparation of L-PRF is straightforward: 1. Blood is drawn into test tubes without anticoagulant 2. It's immediately centrifuged (typically at 2700 rpm for 12 minutes or 1300 rpm for 8 minutes depending on the protocol) 3. During centrifugation, the blood naturally coagulates 4. The result is three layers: platelet-poor plasma at the top, the PRF clot in the middle, and red blood cells at the bottom[1][5] 5. The PRF clot is removed and can be pressed into a membrane if needed[1] ## Composition and Mechanism L-PRF contains: - Up to 50% of the leukocytes and 97% of platelets from the original blood[6] - Growth factors including PDGF, TGF-β, VEGF, EGF and others[1][6] - A fibrin matrix that acts as a reservoir for sustained growth factor release[6] The polymerization of fibrin during preparation produces a unique mechanical structure that distinguishes it from other platelet concentrates like PRP[2]. This structure allows for slow and prolonged release of growth factors, closely mimicking the natural wound repair process[2]. ## Clinical Applications L-PRF is used in various clinical settings: - Oral and maxillofacial surgeries - Bone grafting for dental implants - Wound healing - Tissue regeneration - Treatment of medication-related osteonecrosis of the jaw (MRONJ)[2] ## Advantages The benefits of L-PRF include: - Safety (derived from patient's own blood) - Convenience (can be created quickly in-office) - Faster healing and tissue regeneration - Cost-effectiveness - No risk of disease transmission[4][5] L-PRF represents a significant advancement in regenerative medicine by harnessing the body's natural healing processes to improve patient outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Leukocyte Platelet-Rich Fibrin.